BOSTON, Feb. 28, 2017 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a biopharmaceutical company dedicated ...
Niraparib NDA under review by FDA; pre-launch preparations for planned commercial launch well underwayExpanded ...
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc.® (NASDAQ:PTLA) ...
BOSTON, Feb. 28, 2017 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a biopharmaceutical company dedicated ...
SAN DIEGO, Feb. 28, 2017 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage ...
ROCKVILLE, Md., Feb. 28, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical ...
ROCKVILLE, Md., Feb. 28, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical ...
PITTSBURGH, PA--(Marketwired - Feb 28, 2017) - InteloMed, Inc., a leader in the development ...
PITTSBURGH, PA--(Marketwired - Feb 28, 2017) - InteloMed, Inc., a leader in the development ...
AT THE GENITOURINARY CANCERS SYMPOSIUM ORLANDO (FRONTLINE MEDICAL NEWS) – In the largest assessment ...
A randomized controlled multicenter study published by Carson et al. in JAMA concluded that, ...
FROM JAMA The increasing incidence of subdural hematoma may be linked to increasing use ...
FROM JAMA SURGERY Investment in advanced palliative care planning has the potential to improve ...